DCF — MARSHFIELD MEDICAL CENTER-MINOCQUA
Enterprise Value: $-248.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-248.5M
Enterprise Value
$-77.9M
PV of Cash Flows
$-170.6M
PV of Terminal Value
$-274.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $133.5M | $-15.9M | -12.0% | $-21.5M | $-19.6M |
| Year 2 | $137.5M | $-15.0M | -11.0% | $-20.8M | $-17.2M |
| Year 3 | $141.7M | $-14.0M | -10.0% | $-20.0M | $-15.0M |
| Year 4 | $145.9M | $-13.7M | -9.0% | $-19.9M | $-13.6M |
| Year 5 | $150.3M | $-13.7M | -9.0% | $-20.1M | $-12.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-248.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$129.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12394770402382806
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5